Pfenex Inc. - Investors http://pfenex.investorroom.com/ Pfenex Announces Departure of Chief Medical and Scientific Officer Dr. Hubert Chen http://pfenex.investorroom.com/news-releases?item=125 Thu, 16 Aug 2018 16:10:00 -0400 http://pfenex.investorroom.com/news-releases?item=125 Pfenex Reports Second Quarter Results and Provides Business Update http://pfenex.investorroom.com/news-releases?item=124 Wed, 08 Aug 2018 16:10:00 -0400 http://pfenex.investorroom.com/news-releases?item=124 Pfenex to Host Conference Call and Webcast Reporting Second Quarter Financial Results on Wednesday, August 8 http://pfenex.investorroom.com/news-releases?item=123 Wed, 25 Jul 2018 16:48:00 -0400 http://pfenex.investorroom.com/news-releases?item=123 Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114) http://pfenex.investorroom.com/news-releases?item=122 Thu, 12 Jul 2018 08:15:00 -0400 http://pfenex.investorroom.com/news-releases?item=122 Pfenex Set to Join Russell 2000® Index http://pfenex.investorroom.com/news-releases?item=121 Fri, 22 Jun 2018 17:16:00 -0400 http://pfenex.investorroom.com/news-releases?item=121